^
11ms
New P1 trial
|
IFNG (Interferon, gamma) • IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • IL2 (Interleukin 2) • IL10 (Interleukin 10)
|
R130
over1year
New P1 trial • Oncolytic virus • IO biomarker • Metastases
|
IL6 (Interleukin 6) • CXCL8 (Chemokine (C-X-C motif) ligand 8) • IL2 (Interleukin 2) • IL10 (Interleukin 10) • IL4 (Interleukin 4)
|
R130
over1year
New P1 trial • Oncolytic virus • IO biomarker • Metastases
|
IL6 (Interleukin 6) • CXCL8 (Chemokine (C-X-C motif) ligand 8) • IL2 (Interleukin 2) • IL10 (Interleukin 10) • IL4 (Interleukin 4)
|
R130
over1year
New P1 trial • Oncolytic virus • IO biomarker • Metastases
|
IL6 (Interleukin 6) • CXCL8 (Chemokine (C-X-C motif) ligand 8) • IL2 (Interleukin 2) • IL10 (Interleukin 10) • IL4 (Interleukin 4)
|
R130
over1year
New P1 trial
|
IL6 (Interleukin 6) • CXCL8 (Chemokine (C-X-C motif) ligand 8) • IL2 (Interleukin 2) • IL10 (Interleukin 10) • IL4 (Interleukin 4)
|
R130
over1year
New P1 trial • Oncolytic virus • IO biomarker
|
IL6 (Interleukin 6) • CXCL8 (Chemokine (C-X-C motif) ligand 8) • IL2 (Interleukin 2) • IL10 (Interleukin 10) • IL4 (Interleukin 4)
|
R130